Faire progresser l’innovation pharmaceutique : la certification CEP de Brains Bioceutical permettra de simplifier le développement de médicaments à base de cannabinoïdes, en s’inspirant du médicament contre l’épilepsie à base de CBD de Jazz Pharmaceuticals, avec un chiffre d’affaires prévisionnel de 1,4 milliard de dollars en 2024 SANDWICH, Royaume-Uni, 23

Le détaillant néo-zélandais exploitant 90 magasins d’articles ménagers et de sport se reposera sur la plateforme AI-Merchandising & Supply Chain pour améliorer ses prévisions, la gestion de ses stocks et bien plus encore NEW YORK, 22 août 2024 (GLOBE NEWSWIRE) — Impact Analytics™, le pionnier des solutions de planification, de

WATERFORD, Ireland, Aug. 22, 2024 (GLOBE NEWSWIRE) — In a bid to double down on underage gambling, regulated online casinos globally will forfeit the winnings of those found to be under the legal age. As the gambling industry draws a firm line against illegal play, it is also adopting cutting-edge

Bitget Adds Support for PayPal (PYUSD) Stablecoin on Solana Blockchain VICTORIA, Seychelles, Aug. 22, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has added trading support for PayPal’s PYUSD stablecoin on Solana blockchain, increasing the availability of multichain tokens. This enables smooth transactions of PYUSD on

Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection BSPG Laboratories SANDWICH, United Kingdom, Aug. 22, 2024 […]

90-Store New Zealand-Based Home Goods and Sporting Goods Retailer Will Use the AI-Merchandising & Supply Chain Platform to Enhance Forecasting, Inventory Management and More NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) — Impact Analytics™, the pioneer in AI-powered planning, merchandising and pricing solutions, today announced it has partnered with Briscoe

caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug. 20, 2024 (GLOBE NEWSWIRE) — Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin’s current candidate vaccines toward licensure and expand its pipeline. A member

caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug. 20, 2024 (GLOBE NEWSWIRE) — Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin’s current candidate vaccines toward licensure and expand its pipeline. A member